Easton Pharmaceuticals (Easton Pharmaceuticals) Net Change in Cash : $-0.20 Mil (TTM As of Sep. 2021)

View and export this data going back to . Start your Free Trial

What is Easton Pharmaceuticals Net Change in Cash?

Net Change in Cash is calculated as the total of Cash Flow from Operations , Cash Flow from Investing, Cash Flow from Financing, and Effect of Exchange Rate Changes.

Easton Pharmaceuticals's Net Change in Cash for the three months ended in Sep. 2021 was $-0.08 Mil. Its Net Change in Cash for the trailing twelve months (TTM) ended in Sep. 2021 was $-0.20 Mil.

Easton Pharmaceuticals Net Change in Cash Historical Data

The historical data trend for Easton Pharmaceuticals's Net Change in Cash can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Easton Pharmaceuticals Net Change in Cash Chart

Easton Pharmaceuticals Annual Data

Trend

Dec01

Dec02

Dec03

Dec04

Dec18

Dec19

Dec20

Net Change in Cash

Get a 7-Day Free Trial

-0.19

0.04

-0.01

0.49

-0.21

Easton Pharmaceuticals Quarterly Data
	Jun02	Sep02	Dec02	Mar03	Jun03	Sep03	Dec03	Mar04	Jun04	Sep04	Dec04	Mar05	Jun05	Sep05	Dec18	Dec19	Dec20	Mar21	Jun21	Sep21
Net Change in Cash	Get a 7-Day Free Trial															-	-	-0.10	-0.02	-0.08

Easton Pharmaceuticals Net Change in Cash Calculation

Easton Pharmaceuticals's Net Change in Cash for the fiscal year that ended in Dec. 2020 is calculated as

Net Change in Cash	=	Cash Flow from Operations	+	Cash Flow from Investing	+	Cash Flow from Financing	+	Effect of Exchange Rate Changes
	=	-0.189	+	-0.019	+	0	+	0
	=	-0.21

Easton Pharmaceuticals's Net Change in Cash for the quarter that ended in Sep. 2021

Net Change in Cash = Cash Flow from Operations + Cash Flow from Investing + Cash Flow from Financing + Effect of Exchange Rate Changes

= -0.059 + -0.019 + 0 + 0

= -0.08

Net Change in Cash for the trailing twelve months (TTM) ended in Sep. 2021 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.20 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Easton Pharmaceuticals Net Change in Cash Related Terms
Thank you for viewing the detailed overview of Easton Pharmaceuticals's Net Change in Cash provided by GuruFocus.com. Please click on the following links to see related term pages.

Easton Pharmaceuticals (Easton Pharmaceuticals) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Easton Pharmaceuticals Inc (OTCPK:EAPH) » Definitions » Net Change in Cash

Comparable Companies

FPSUF GCAN ACUR ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4507 CTLT SZSE:000538 NSE:DIVISLAB TSE:4523 XSWX:VIFN VTRS SHSE:600196 NBIX SZSE:000963 HKSE:03692 SZSE:002001

Traded in Other Exchanges

N/A

Address

2 Bloor Street East, Suite 3500, Toronto, ON, CAN, M4W 1A8

Website

http://www.eastonpharmaceuticalsinc.com

Easton Pharmaceuticals Inc is a diversified specialty pharmaceutical company. It owns and develops proprietary transdermal delivery technology and therapeutic over the counter products and drugs to treat cancer and other diseases. The company also owns exclusive distribution rights in Mexico and Latin America for patented women's diagnostic and preventative care products. It is focused on the development of product Viorra. The firm's products include Nauseasol, Skin Renou HA, Kenestrin gel, and XILIVE, among others.

Easton Pharmaceuticals (Easton Pharmaceuticals) Headlines

From GuruFocus

Easton Pharmaceuticals Strengthens its Board of Directors While Enhancing Existing Businesses and Moves Towards New Sectors and Industries
By Marketwired Marketwired • 06-25-2018

Easton Pharmaceuticals Reaches Agreement to Take Over Hotel and $17,000,000 Real Estate Asset in Heart of Toronto, Canada
By Marketwired Marketwired • 09-27-2018

Easton Pharmaceuticals Completes Purchase of Development Project with Total Projected Profit in Excess of $30 Million
By Marketwired Marketwired • 12-18-2018

Easton Announces Signing of Joint Venture Agreement for the Purchase and Development of 9 Townhomes with Revenue in Excess of $4 Million and Provides Update on its Framing Contract with Revenues of $770K for Q1
By ACCESSWIRE AccessWire • 04-12-2019

Easton Closes Purchase of Food Processing Company Specializing in Baked Goods with Projected Revenues Over $20,000,000 per Year and Positioned to Enter the Cannabis Edibles Market
By ACCESSWIRE AccessWire • 04-24-2019

Easton Announces Filing of Its Financial Statements for the Year Ended December 31, 2018 with a Revenue Increase of 145% Over 2017 and Provides General Business Update
By ACCESSWIRE AccessWire • 04-12-2019

Easton Pharmaceuticals Announces BAYER Agreement Update
By Marketwired Marketwired • 04-16-2018

Easton Commences Cannabis Edibles Division and Announces Updates on Its Filing for the Period Ended December 31, 2018
By ACCESSWIRE AccessWire • 04-12-2019

Easton Pharmaceuticals Announces That Easton and Its JV Partner, Alliance Group, Have Generated $40,000 in Revenues in the First Week of Operations
By Marketwired Marketwired • 06-11-2018

Easton Announces Updates on Its $2,600,000 Framing Contract to Construct 150 Homes as Well as Other Initiatives
By Marketwired Marketwired • 02-05-2019